Q3 2025 Earnings Call Transcript November 4, 2025 Corcept Therapeutics Incorporated misses on earnings expectations. Reported ...

Teva Canada welcomes the recent announcement from Québec’s Ministry of Health regarding changes to the reimbursement ...

The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are pointing lower ahead of the open, as ...

Revenues grew by 3.4 percent to $4.48 billion from $4.33 billion year-on-year, on the back of strong growth across its brands ...

Teva Pharmaceutical (TEVA) delivered a compelling performance in the third quarter, with financial results exceeding market expectations. The company reported quarterly revenue of $4.48 billion, a 3% ...

Teva Pharmaceutical Industries ( TEVA +20.23%) had a day on the stock market to remember on Wednesday. The drugmaker 's share ...

Teva Pharmaceutical CEO Richard Francis speaks about 3Q earnings on Bloomberg BusinessWeek with Bloomberg's Katie Greifeld ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...

Teva Pharmaceutical is one of the leading global generic drug manufacturers. By our estimate, roughly 70% of its total revenue is derived from generics and off-patent branded drugs. Generic drugs in ...

Executive VP Eric Hughes described the pipeline's late-stage assets, including olanzapine LAI on track for FDA submission, DARI, duvakitug, and emrusolmin, citing potential peak sales of over $11 ...

Teva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia (TD). | Teva Pharmaceuticals has a new ...

Toast Inc (NYSE: TOST) gained 9.3% to $39.00 after the company reported better-than-expected quarterly financial results. Also, Morgan Stanley maintained an Overweight rating on the stock and raised ...